Drug Patent Expirations for the Week of June 9, 2024

ABRAXANE (paclitaxel) Bristol-myers Patent: 8,314,156 Expiration: Jun 9, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…

New patent for Merck Sharp drug WELIREG

Annual Drug Patent Expirations for WELIREG Welireg is a drug marketed by Merck Sharp Dohme and is included in one NDA. It is available from one supplier. There are two…